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Abstract
Previous works of our group demonstrated that xenobiotic metabolism by brain microsomes or cultured cerebral cells may
promote the formation of reactive oxygen species. In order to characterise the risk of oxidative stress to both the central
nervous system and the blood-brain barrier, we measured in the present work the release of superoxide in the culture medium
of rat cerebrovascular endothelial cells during the metabolism of menadione, anthraquinone, diquat or nitrofurazone. Assays
were run in the same experimental conditions on primary cultures of rat neurones and astrocytes. Quinone metabolism
efficiently produced superoxide, but the production of radicals during the metabolism of diquat or nitrofurazone was very
low, as a probable result of their reduced transport inside the cells. In all cell types assayed, superoxide production was time-
and concentration-dependent, and cultured astrocytes always produced the highest amounts of radicals. Superoxide
formation by microsomes prepared from the cultured cells was decreased by immunoinhibition of NADPH-cytochrome P450
reductase or by its irreversible inhibition by diphenyliodonium chloride, suggesting the involvement of this flavoprotein in
radical production. Cerebrovascular endothelial cells cultured on collagen-coated filters produced equivalent amounts of
superoxide both at their luminal side and through the artificial basement membrane, suggesting that in vivo, endothelial
superoxide production may endanger adjacent astrocytes and neurones. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The endothelium of cerebral microvessels presents
speci¢c and unique properties, forming the blood-
brain barrier (BBB) that controls the bi-directional
exchange of solutes between blood and the cerebral
parenchyma. It is basically formed by a monocellular
layer of endothelial cells (brain endothelial cells,
BEC) sealed by tight junctions, but pericytes em-
bedded in the basal membrane of BEC, perivascular
astrocytes and some microglial cells should partici-
pate to BBB function [1^3]. The BBB protects the
central nervous system (CNS) against potentially
neurotoxic substances or molecules able to alter neu-
ronal microenvironment and normal function [2]. A
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yl]2,5-diphenyl tetrazolium bromide; L-NAME, N-g-nitro-L-argi-
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metabolic barrier increases the protection a¡orded
by the physical BBB, due to the endothelial activity
of enzymatic systems able to metabolise e⁄ciently
lipophilic permeant exogenous molecules (for a re-
view, see [3]).
One of the most important functions of the BBB is
to supply oxygen to the brain, which has a continu-
ous, high oxygen consumption and glucose-depen-
dent oxidative metabolism to meet its energy de-
mands. The very high capacity to oxidise glucose
generates reactive oxygen species (ROS) as normal
by-products of mitochondrial respiratory chain activ-
ity [4,5]. ROS may be also produced during diverse
pathophysiological states, like in£ammation or anox-
ia-oxygenation sequences, or by cytochrome P450-
dependent xenobiotic metabolism. As the brain con-
tains relatively low levels of antioxidant defences and
a high unsaturated lipid content [6], it seems espe-
cially vulnerable to oxidative stress [7]. Moreover,
oxidative injury to the endothelium causes disruption
of the barrier function and oedema, and increases the
susceptibility to further oxidant injury [8]. Accord-
ingly, it has been shown that free radical attack on
con£uent cultured BEC may promote an increase of
the passive permeability to sucrose [8^10], that can
be reversed in the case of a moderate or short-lasting
oxidative stress [10]. Therefore the cerebrovascular
endothelium, even possessing high amounts of enzy-
matic or non-enzymatic antioxidants [6], represents a
critical target for oxidative injury, since damage may
result in the loss of both metabolic function and
barrier properties, allowing a further secondary dam-
age to the CNS.
It is noteworthy that BEC not only can be the
target of oxidant injury, but they can also produce
ROS by themselves. BEC represent the only cell
group in the CNS that are continuously exposed to
circulating drugs and putative toxicants, which, in
turn, may modify BBB function by a more or less
reversible alteration of BEC speci¢c membrane prop-
erties or a decrease in speci¢c transport activities [2].
In normal aerobic conditions, some xenobiotics such
as nitroheterocycles, imminium ions or quinones,
when metabolised by isolated brain microsomes, cer-
ebral microvessels or choroid plexus [11], or cultured
BEC [12] may undergo an NADPH-dependent
monoelectronic reduction. This results in the forma-
tion of molecular radicals able to transfer their sup-
plementary electron to oxygen, thus promoting the
formation of the superoxide radical O32 and the
starting compound, a mechanism known as futile
redox cycling [13]. Superoxide radical may gain ac-
cess to the extracellular space by di¡usion through
an anion channel across the plasma membrane [14].
Alternatively, superoxide and related ROS like hy-
droxyl radical or peroxynitrite may alter cellular con-
stitutive or functional macromolecules, namely nu-
cleic acids, polyunsaturated lipids, proteoglycans
and proteins [15,16]. Moreover, oxidant alterations
to BEC, linked to a decrease in glutathione and as-
corbic acid, as well as in free radical scavenging en-
zymes, represent major contributing factors in ageing
and degenerative processes such as Alzheimer’s and
Parkinson’s diseases [17^19].
The aim of the present study was (i) to characterise
the ability of rat BEC in primary culture or co-cul-
ture with astrocytes to produce superoxide radicals,
when exposed to di¡erent xenobiotics; (ii) to show
that primary cultures of rat astrocytes and neurones
also produce superoxide radicals when exposed to
these xenobiotics; and (iii) to investigate the involve-
ment of the endoplasmic reticulum membrane en-
zyme NADPH-cytochrome P450 reductase (EC:
1.6.2.4) in superoxide radical formation. As BEC
possess a functional polarity, several enzymes and
transport systems being located on the luminal mem-
brane exclusively, whereas other on both membranes
[20], we also measured superoxide production at both
the luminal and antiluminal membrane sides.
2. Materials and methods
2.1. Chemicals
Nitrofurazone (2-[5-nitro-(2-furanyl)methylene]-
hydrazincarboxamide), dextran, L-glutamine, anti-
factor VIII and anti-glial ¢brillary acidic protein
(GFAP) antibodies, superoxide dismutase (SOD,
3000 U/mg) and diphenyliodonium chloride were
purchased from Sigma Chemical Co. (Saint-Quen-
tin-Fallavier, France), and menadione (2-methyl-
1,4-naphthoquinone) and anthraquinone (2-anthra-
quinonesulfonic acid, sodium salt) from Merck
(Darmstadt, Germany). Diquat dibromide was ob-
tained from Riedel-de-Ha«en (Friedrichstahl, Ger-
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many). Cytochrome c, type I collagen, collagenase-
dispase and NADPH were obtained from Boehr-
inger-Mannheim (Meylan, France). Cell culture
products were purchased from Gibco-BRL (Eragny,
France). All other routine chemicals were from Sig-
ma.
2.2. Animals
Animals used in this study were Sprague-Dawley
rats supplied by I¡a-Credo (Saint Germain-sur-l’Ar-
bresle, France). Rats were housed separately and
maintained on a 12 h/12 h light/dark cycle in a tem-
perature-controlled environment (21^22‡C), with free
access to tap water and standard rodent chow. All
procedures have been submitted to the approbation
of the local Ethics Committee, and the recommenda-
tions of the National Research Council’s guide for
the care and use of laboratory animals have been
strictly followed.
2.3. Cell cultures
Pure primary cultures of brain endothelial cells
were prepared from the brains of young adult male
rats (200^220 g) according to [21]. Young adult rats
were used in order to obtain enough microvessels to
prepare useful quantities of BEC. Brie£y, rats were
killed by cervical dislocation and the brains were
rapidly removed and chilled in the homogenisation
medium at 0^2‡C. The cortices were gently homoge-
nised with a Dounce homogeniser in Dulbecco’s
modi¢ed Eagle’s medium (DMEM) F12 supple-
mented with 100 U/ml penicillin, 100 Wg/ml strepto-
mycin and 2 mM L-glutamine. After centrifugation
at 600Ug for 5 min, the pellet was dispersed in a
1 mg/ml collagenase-dispase solution in the same me-
dium for 1 h at 37‡C and centrifuged at 1000Ug.
The sediment obtained was resuspended in a 26%
(w/v) dextran solution in Hank’s balanced saline so-
lution (HBSS) and centrifuged at 2500Ug for 10
min. The microvessel fragments in the pellet were
resuspended in a solution of 1 mg/ml collagenase-
dispase and incubated for 3 h at 37‡C under a slow
agitation to separate the endothelial cells. The sus-
pension was then centrifuged at 1000Ug for 5 min,
and the sediment was layered onto the top of a Per-
coll gradient (HBSS/Percoll, 50/50, v/v). After centri-
fugation at 2000Ug for 15 min, the endothelial cells
were taken from the layer and suspended in the cul-
ture medium supplemented with 5% foetal calf serum
and 5% rat serum. They were cultured in 6-well
plates coated with rat tail type I collagen (20 Wg/
cm2), and were grown at 37‡C in a humidi¢ed incu-
bator in a 5% CO2 atmosphere for 15 days to reach
con£uence. At con£uence, BEC stopped their
growth, thus were considered as mature cells. Con-
trols of purity were routinely performed by visual
examination and immuno-detection of factor VIII,
a speci¢c marker of endothelial cells. Cultures usu-
ally contained more than 90% factor VIII-positive
cells, and were rejected when contamination with
other cell types, like pericytes, was higher than 10%.
Rat brain astrocyte primary cultures were pre-
pared as described in [22]. New-born rat cerebral
cortices were homogenised into DMEM culture me-
dium supplemented with 2 mM L-glutamine, 50 Wg/
ml gentamycine and 10% (v/v) foetal bovine serum
by passing through a 80 Wm nylon sieve. Cells were
cultured in plastic dishes in the same incubator. The
monocellular layer reached con£uence after 2 weeks
of culture, and experiments were usually performed
2^4 days after. Purity of the culture was estimated by
immuno-characterisation of GFAP, as a marker of
glial ¢laments in astrocyte cytoplasm. More than
95% of the cells were identi¢ed as type I astrocytes.
Neurones in primary cultures were prepared from
rat 14 days old embryos exactly as described in [23].
Cells were considered mature after 1 week of culture,
and were usually assayed between day 9 and day 11.
Neurone speci¢c enolase was used as a speci¢c
marker for the purity of the cultures, and more
than 95% of the cells were usually identi¢ed as neu-
rones. No GFAP reactivity was detected in neuronal
cultures.
Co-cultures of BEC and primary astrocytes have
been also prepared, as astrocytes release in their cul-
ture medium some growth and di¡erentiation factors
needed by BEC for the optimal maintenance of their
speci¢c properties, thus controlling the potency of
the BBB [24,25]. BEC were cultured on 25 mm diam-
eter permeable, collagen-coated polycarbonate mem-
branes placed on corresponding 6-well culture plates
(Falcon Cell Culture Inserts, Becton Dickinson,
Franklin Lakes, NJ, USA). Astrocytes were simulta-
neously cultured on the bottom of the chamber,
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therefore allowing the conditioning of the BEC cul-
ture medium.
2.4. Relevance of the experimental blood-brain barrier
model
In order to assess the validity of our in vitro BBB
model, transendothelial resistance measurements and
sucrose permeability assays have been carried out
systematically. For transendothelial resistance mea-
surement, endothelial cells were cultured on micro-
porous polycarbonate membrane inserts (Falcon cell
culture inserts, 23.1 mm, pore size 0.4 Wm). For co-
culture assays, astrocytes were cultured on the bot-
tom of the same well. After endothelial cell con£u-
ence, inserts were placed in an EVOM apparatus
(World Precision Instruments, Inc., Sarasota, USA)
containing culture medium at 25‡C. Resistance of
inserts without cells was subtracted from transendo-
thelial resistance before ¢nal resistance (usually high-
er than 50 6 cm2) was calculated. Sucrose permeabil-
ity, which is a good index of non-permeability of the
cellular layer to large molecules, was also measured
on BEC cultured on inserts using the [14C]-labelled
molecule exactly as described in [10]. Evidence for a
very limited paracellular permeability was deduced
from the permeability to sucrose which was usually
lower than 4U1034 cm/min.
2.5. Superoxide radical measurement
Superoxide radicals released by the cultured cells
in their incubation medium were quanti¢ed by a sec-
ond derivative spectrophotometric method as de-
scribed in [23], using acetyl-cytochrome c as the elec-
tron acceptor. Acetylation e⁄ciency was checked by
the inability of acetyl-cytochrome c to be reduced by
microsomal NADPH-cytochrome P450 reductase in
the presence of NADPH. In our assays, only acetyl-
cytochrome c solutions containing less than 5% un-
acetylated cytochrome c have been used.
To prevent both possible spectral interferences and
radical trapping by components of the culture me-
dium during spectrophotometric measurements, cul-
tured cells were rinsed twice with 2 ml of a bu¡ered
saline solution (BSS, 150 mM NaCl, 4 mM KCl, 3.15
mM CaCl2, 1.2 mM MgCl2 and 5 mM glucose, bu¡-
ered with 15 mM HEPES at pH 7.4) immediately
before exposure to xenobiotics. Then 2 ml BSS con-
taining 60 WM acetyl-cytochrome c with di¡erent
concentrations of menadione, anthraquinone, nitro-
furazone or diquat was added to each culture well
for 60 min at 37‡C. Xenobiotics were used at a max-
imal concentration corresponding to their apparent
Km measured on rat brain microsomes [11]. Aliquots
of the incubation medium (80 Wl/well) were sampled
at various time intervals (0, 10, 20, 30, 45, and 60
min), and analysed for the amount of reduced acetyl-
cytochrome c at 550 nm in a double-beam spectro-
photometer (Uvikon 820, Kontron) with the same
volume of BSS in the reference cuvette. Calibration
was performed by complete reduction of acetyl-cyto-
chrome c by adding sodium dithionite. At the end of
the measurement, cultured cells were rinsed with BSS
and scraped o¡ with 0.1 M Tris bu¡er, pH 7.4, for
the determination of protein content according to
[26], using bovine serum albumin as a standard.
SOD, when added between 0.3 to 300 Wg/ml
of incubation medium during cell incubation with
xenobiotics, e⁄ciently inhibited the reduction of ace-
tyl-cytochrome c (excepted with menadione, see Sec-
tion 3), thus con¢rming the release of superoxide
radicals by the cultured cells during xenobiotic me-
tabolism.
2.6. Polarity of superoxide production
Accumulating evidence indicates that BEC possess
asymmetrically-localised enzymes, receptors, and car-
rier-mediated transport systems like P-glycoprotein
that engender a truly polarised phenotype [20,27].
As blood-borne lipophilic xenobiotics should enter
the endothelial cells by the luminal side, it seemed
important to check if the resulting superoxide radical
release occurs only at the luminal side or at the ablu-
minal, i.e. astrocytic and neuronal, side, or at both.
Therefore, BEC were cultured either on well bottom
for total radical production measurements, or on
microporous polycarbonate inserts covered with 1.5
ml culture medium, in pure culture or in co-culture
with astrocytes as described previously. Before mea-
surements, the inserts were ¢lled with 1.5 ml BSS
containing a precise concentration of a xenobiotic,
and placed in new wells ¢lled with 2 ml BSS, without
astrocytes. Aliquots of BSS were sampled simultane-
ously in the insert (corresponding to the luminal side)
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and in the well (antiluminal side) for superoxide mea-
surement as described previously.
2.7. Cell viability assessment
In order to assess the viability of the cultured cells
and the intactness of their membranes during and
after the treatment with xenobiotics, two di¡erent
tests were performed on control cultures: an exclu-
sion test with Trypan blue to check the quality of cell
membranes and a 3-[4,5-dimethylthiazol-2-yl]2,5-di-
phenyl tetrazolium bromide assay (Sigma MTT
test) to estimate viable cell number by detection of
mitochondrial dehydrogenase activities in these cells
[28]. After a 2 h incubation at 37‡C, the medium was
removed and cells were lysed and solubilised by ad-
dition of isopropanol^HCl 0.1 M (1/1, v/v). Reduced
MTT absorbance was measured at 540 nm, using a
microculture plate reader. The viability in treated
cultures was expressed as a percentage of the mean
absorbance of control cultures, following substrac-
tion of the background absorbance of wells without
cells.
Measurement of reduced glutathione content of
cultured cells was performed by an HPLC procedure
as described in [29].
2.8. Enzymatic assays
NADPH-cytochrome P450 reductase activity was
monitored by spectrophotometric recording of the
NADPH-dependent reduction of cytochrome c at
550 nm and 25‡C. The reaction mixture contained
50 Wg cell homogenate and 50 WM cytochrome c in
a 330 mM potassium phosphate, 0.1 mM EDTA
bu¡er at pH 7.4. The reaction was started by the
addition of NADPH at a ¢nal concentration of 50
WM, as described in [30]. Cell homogenates were ob-
tained after scraping o¡ the cells in the same bu¡er,
and sonicating them for 15 s at a 20 watt output
power. Microsomes were prepared from these homo-
genates as previously described for neurones [30].
Inhibition of NADPH-cytochrome P450 reductase
activity of microsomes isolated from cultured cells
was achieved either by addition at di¡erent concen-
trations (0.125, 0.25 and 0.5 mM) of diphenyliodo-
nium chloride that forms covalent binding to two
di¡erent sites of the protein [31] or by immunoinhi-
bition with increasing concentrations of an antibody
developed against rat liver NADPH-cytochrome
P450 reductase, prepared as described previously
[30].
Q-Glutamyltransferase activity was measured on
cell homogenates by using Sigma Diagnostics (St.
Louis, MO, USA) kits (procedure No. 545-A), ex-
actly as recommended by the supplier.
2.9. Statistical analysis
Data are expressed as the mean þ S.D. For statis-
tical analysis, Student’s t-test was used to compare
the results obtained from multiple groups after AN-
OVA was performed, P6 0.05 was considered signif-
icant.
3. Results
The xenobiotics used in this study were selected
among drugs or environmental toxicants which be-
long to three di¡erent chemical families: quinones
for menadione and anthraquinone, imminium ions
for diquat and nitroheterocycles for nitrofurazone.
All these molecules generate superoxide radicals dur-
ing microsomal NADPH-dependent reductive me-
tabolism, and the amount of superoxide formed is
related to the reduction potential of these molecules
[32]. The chemical structure of the molecules studied
in this work is depicted in Fig. 1.
Fig. 1. Chemical structure of the xenobiotics used in this study.
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3.1. Viability of the cultured brain cells after
xenobiotic treatment
Exposure of either BEC, astrocytes or neurones in
primary culture for 60 min to 5 WM menadione or
980 WM anthraquinone did not induce cell death, as
shown by the MTT reduction assay and the Trypan
blue exclusion test. These results suggest that the
exposure to xenobiotics at a concentration corre-
sponding to the apparent Km of their NADPH-de-
pendent reduction by brain microsomes [11] do a¡ect
neither cell membrane intactness nor mitochondrial
enzymatic activity. They also con¢rm that the release
of superoxide into the culture medium was not linked
to an increase in membrane permeability due to
xenobiotics toxicity or to cell death. Higher concen-
trations of xenobiotics were not used, as the viability
of the cells decreased very rapidly (50% for 5 mM
anthraquinone and 75% for 0.25 mM menadione
after 60 min of incubation) (not shown).
In accordance with these observations, the amount
of reduced glutathione in endothelial cells treated by
5 WM menadione for 30 min was not signi¢cantly
di¡erent from that of total glutathione (18.56 þ 0.24
Wg/ml mg protein versus 21.03 þ 0.31 Wg/ml mg pro-
tein, n = 3) suggesting that the endothelial antioxi-
dant status was not signi¢cantly altered in these ex-
perimental conditions.
3.2. Superoxide radical production
In the presence of 5 WM menadione or 980 WM
anthraquinone, the three types of cells produced
high amounts of superoxide radicals. However, the
rate of superoxide generation by anthraquinone was
3-fold lower in neurones than in astrocytes or BEC.
Superoxide production was time-dependent and
practically linear for at least 30 min with BEC and
astrocytes and for 60 min with neurones (Table 1A
and B). By contrast, in the presence of 28 WM diquat
or 290 WM nitrofurazone, the rate of superoxide was
maintained at the control level (2.5 nmol/ml mg pro-
tein).
3.3. Concentration-dependence of xenobiotic-
promoted superoxide formation
The measurement of the initial rates of superoxide
radical production during incubation of cultured
BEC, astrocytes and neurones with 0.1 to 5 WM me-
Table 1
Superoxide anion production by cerebrovascular endothelial
cells (BEC), astrocytes and neurones in primary cultures in the
presence of di¡erent drugs and xenobiotics added to the culture
medium
(A): menadione 5 WM:
Time (min) BEC Astrocytes Neurones
0 5.9 þ 1.2 1.7 þ 0.3b 3.6 þ 0.1a
10 50.4 þ 3.9 47.3 þ 5.2 37.2 þ 4.9a
20 77.7 þ 1.8. 85.2 þ 6.8b 56.6 þ 2.2b
30 106.6 þ 3.6 104.7 þ 5.1 78.6 þ 4.2b
45 113.8 þ 1.2 116.5 þ 9.1a 104.6 þ 4.6a
60 111.2 þ 1.2 130.2 þ 1.7b 117.9 þ 1.4b
(B): anthraquinone 980 WM:
0 10.2 þ 3.1 47.7 þ 10.4a 3.6 þ 0.4a
10 77.7 þ 16.4 86.7 þ 4.6 21.0 þ 0.2b
20 114.4 þ 24.4 132.6 þ 16.3 35.4 þ 4.7b
30 139.5 þ 29.3 178.2 þ 25.1 43.3 þ 0.8b
45 159.3 þ 22.3 215.7 þ 23.1 50.8 þ 0.9b
60 184.0 þ 50.8 246.1 þ 26.4 81.9 þ 1.1b
Values are the mean þ S.D. of three assays.
aNeurone or astrocyte superoxide production signi¢cantly di¡er-
ent from the production displayed by BEC, P6 0.05.
bP6 0.01, Student’s t-test.
Table 2
Apparent kinetic parameters of the production of superoxide in the presence of menadione and anthraquinone by primary cultures of
cerebrovascular endothelial cells (BEC), astrocytes and neurones
Menadione Anthraquinone
BEC Astrocytes Neurones BEC Astrocytes Neurones
Km 1.78 4.47 0.27 1930 1020 657
Vmax 4.16 7.5 2.13 11.69 8.33 2.65
Vmax/Km 2.33 1.67 7.88 0.006 0.008 0.004
Km are expressed as WM, and Vmax as nmol/min mg protein. Menadione concentrations varied from 0.1 to 5 WM and anthraquinone
from 0.1 to 1 mM. Values are the mean of three assays.
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nadione and 0.1 to 1 mM anthraquinone showed a
concentration-dependent increase in superoxide
anion amounts in the culture medium that was linear
during the ¢rst 5 min of measurement (not shown).
These experiments allowed to calculate the corre-
sponding apparent kinetic parameters Km and Vmax
(Table 2) from Lineweaver-Burk plotting. For the
three cell types, the highest a⁄nity was displayed
toward menadione, and was 250- to 1000-fold higher
than toward anthraquinone. Astrocytes displayed the
highest Vmax values in agreement with their high
superoxide anion production, whereas neurones
showed the highest a⁄nity (about 10-fold higher as
compared to BEC or astrocytes) and the best meta-
bolic e⁄ciency de¢ned as the ratio Vmax/Km toward
these two molecules.
To characterise the nature of the radicals formed
during these experiments, SOD was added in the
culture medium of BEC. Superoxide formation in
the presence of 980 WM anthraquinone was fully pre-
vented by 3 Wg SOD/ml culture medium after 10 min,
whereas 30 Wg SOD/ml medium were required to
obtain the same result after 20 min (Fig. 2A). How-
ever, after exposure of cells to 5 WM menadione, the
inhibition recorded with all SOD concentrations was
never higher than 30% (Fig. 2B).
3.4. Involvement of NADPH-cytochrome P450 in
superoxide production
Previous works suggested that the xenobiotic-de-
Fig. 2. Inhibition of superoxide anion production by superoxide
dismutase (SOD) on primary cerebrovascular endothelial cells
treated by 980 WM anthraquinone (A) and 5 WM menadione
(B). Values are the mean þ S.D. of three assays.
Table 3
NADPH-cytochrome P450 reductase activities in homogenates
of rat, cerebrovascular endothelial cells (BEC), astrocytes and
neurones in con£uent primary culture
Cultured cell type Reductase activity, nmol/min mg
protein
BEC 9.07 þ 1.93
Astrocytes 18.45 þ 5.21a
Neurones 10.75 þ 2.58
Values are the mean þ S.D. of three assays.
aSigni¢cantly di¡erent from BEC (P6 0.01, Student’s t-test).
Table 4
Absence of modi¢cations of NADPH-cytochrome P450 reductase activity by astrocytic factors in cultures of cerebrovascular endothe-
lial cells (BEC)
Culture conditions 17 days 24 days
(A) BEC on the well bottom 10.25 þ 1.51 (6) 7.82 þ 2.09 (6)
(B) BEC on insert 9.83 þ 2.23 (7) 8.64 þ 1.24 (6)
(C) BEC on insert, and astrocytes on the well bottom 10.10 þ 1.54 (8) 9.38 þ 2.38 (9)
BEC were cultured either on the bottom of the well (A), or on microporous inserts either alone (B) or with astrocytes co-cultured for
the same duration on the bottom of the well (C). Before the assays, con£uent cell layers were harvested by scraping, homogenised by
sonication, and microsomes were isolated as described in Section 2. Activities are expressed as nmol cytochrome c reduced/min mg
protein þ S.D. (n assays). No signi¢cant di¡erences were observed between data obtained either at 17 days or 24 days of culture.
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pendent production of superoxide in rat cerebral mi-
crovessel homogenates was mediated by NADPH-de-
pendent enzymes [11,32]. Measurement of NADPH-
cytochrome P450 reductase activities in the three
types of cultured cerebral cells showed that astro-
cytes display the highest activity (Table 3). No sig-
ni¢cant changes in NADPH-cytochrome P450 reduc-
tase activity were observed on BEC co-cultured with
astrocytes (Table 4).
Inhibition of NADPH-cytochrome P450 reductase
activity was obtained by incubating BEC microsomes
with diphenyliodonium chloride (DPC). The 5 WM
menadione-mediated superoxide production showed
a linear decrease inversely proportional to DPC con-
centration. The inhibition was comparable to the
percentage of the inhibition of the enzyme activity
measured at the end of the experiments (Fig. 3A).
The same inhibition of both enzyme activity and
superoxide production was obtained using a speci¢c
polyclonal antibody raised against rat liver NADPH-
cytochrome P450 reductase (Fig. 3B).
3.5. Production of superoxide radical as a function of
endothelial cell polarity
When BEC were cultured on porous, collagen-
coated inserts, the formation of superoxide promoted
by 1 mM anthraquinone occurred at both the lumi-
nal and the abluminal sides, the main part being
released on the luminal side, whereas one third of
the total amount of superoxide formed appeared on
the abluminal side (Table 5).
3.6. E¡ect of co-culturing BEC with astrocytes on
enzyme activities and superoxide formation
Previous results clearly demonstrated that astro-
cyte conditioning of the culture medium signi¢cantly
increased Q-glutamyl-transferase expression [25] and
tight junction e⁄ciency [24] in bovine BEC. Using
rat BEC, we measured an appreciable Q-glutamyl-
transferase activity, that was 26.2 þ 5.6 nmol/min
mg protein. For comparison, the activity was
57.3 þ 13.4 nmol/min mg protein in isolated rat brain
microvessel homogenates [33]. Co-culture of rat BEC
with astrocytes did not promote signi¢cant changes
Fig. 3. Comparison of the inhibition of superoxide production
and NADPH-cytochrome P450 reductase activity in the pres-
ence of diphenyliodonium chloride (DPC) (A) or after anti-rat
liver NADPH-cytochrome P450 reductase polyclonal antibody
treatment (B), by primary cerebrovascular endothelial cell ho-
mogenates incubated in the presence of 5 WM menadione.
Table 5
Luminal side and antiluminal side superoxide radical produc-
tion by BEC in the presence of 1 mM anthraquinone
Duration of the
incubation
Luminal side Antiluminal side
45 min 41.52 þ 18.68 22.74 þ 7.28b
60 min 63.28 þ 26.27 44.24 þ 24.37a
BEC were cultured until con£uence on microporous inserts
coated with collagen as described in the Materials and Methods
section. The side on the insert was considered as the cell antilu-
minal plasma membrane. Before assays (n = 12), the culture me-
dium was removed and replaced by a bu¡ered saline solution
containing 10 mM glucose and, in the insert (luminal side),
1 mM anthraquinone. After 45 or 60 min incubation, aliquots
were sampled at both sides of the insert for superoxide content
measurement, expressed as nmol/min mg protein.
aSigni¢cantly di¡erent from luminal side (P6 0.05, Student’s
t-test).
bSigni¢cantly di¡erent from luminal side (P6 0.01, Student’s
t-test).
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in both TER and GGT activity (not shown). In the
same way, no signi¢cant increase in superoxide rad-
ical formation was observed when BEC were co-cul-
tured with astrocytes prior the assays (not shown), in
accordance with the absence of signi¢cant alterations
in NADPH-cytochrome P450 reductase activity in
these experimental conditions (Table 4).
4. Discussion
Most of the speci¢c properties of the BBB have
been evidenced on in vitro models of the BBB, that
are either primary cultures of rat or bovine BEC, co-
cultures of bovine or porcine BEC and rat astrocytes,
or isolated cerebral microvessels [8,27,34,35]. BEC
cultures retain many morphological, enzymatic and
permeability characteristics of the in vivo mammali-
an BBB. Thus, they have been largely used for the
characterisation of drug transport, metabolism, and
toxicity resulting from the formation of reactive me-
tabolites [8,12,20,35,36]. In vivo, neurones are in
close proximity to astrocytes, that are also in close
proximity to cerebral microvessels. Astrocytes pro-
vide a stabilising milieu to neurones, support their
growth, maturation and survival [37] and produce
soluble trophic factors allowing the expression of
the cerebral endothelial cell phenotype [24,25]. On
the other hand, isolated BEC have been shown to
stimulate DNA synthesis and growth of astrocytes
in culture [38]. The role of neurones to induce and
maintain some of the phenotypic properties of BEC,
although poorly understood [39], should be of para-
mount importance. Thus a perfect model for the
study of the interrelationships between these cells
should involve the co-culture of neurones, BEC and
astrocytes, but such an experimental system seems
rather di⁄cult to realise. Co-cultures of bovine
BEC and astrocytes have been considered as the bet-
ter model for the in vitro study of transport activities
occurring at the BBB [8,36], but pure cultures of rat
BEC are convenient for the study of drug metabo-
lism and of related reactive metabolites formation
[12,21]. Whereas bovine BEC properties are strongly
sensitive to astrocytic factors [35], the present results
clearly suggest that, as compared with pure rat BEC
cultures, co-culturing rat BEC with astrocytes do
neither signi¢cantly modify BEC Q-glutamyl-transfer-
ase nor NADPH-cytochrome P450 reductase activ-
ity, and do not alter xenobiotic metabolism-pro-
moted superoxide formation.
The risk of chemical toxicity due to di¡erent drugs
and pollutants at the BBB was characterised by the
demonstration that in the presence of exogenous
molecules, cultured BEC can release relatively high
amounts of superoxide radicals in their culture me-
dium. Menadione and anthraquinone promoted the
formation of large quantities of superoxide, whereas
diquat or nitrofurazone did not. By contrast, we
showed previously that diquat produces high
amounts of superoxide anions when added to brain
subcellular preparations, in which cell plasma mem-
branes are broken [11,40]. The di¡erences observed
in superoxide formation by intact cultured cells could
therefore result from di¡erent rates of transmem-
brane in£ux of the four molecules assayed. Mena-
dione and anthraquinone are very lipophilic substan-
ces (octanol-water partition coe⁄cient s+2.2 [41]),
and are able to cross easily the cellular membrane,
whereas diquat and nitrofurazone (octanol-water
partition coe⁄cient 631.5) are much more polar.
Accordingly, we recently demonstrated that, among
the four molecules assayed, only menadione and an-
thraquinone increased signi¢cantly the passive per-
meability to sucrose of an in vitro model of the
BBB [10], and an other report suggests that para-
quat, a diquat-related compound, does not cross
the BBB after a subcutaneous injection in rat [42].
During an oxidative stress, the permeability of the
BBB increases [8,10], thus allowing normally non-
permeant, potentially toxic molecules to cross the
BBB, modify CNS homeostasis and possibly pro-
mote some damage to the brain [43].
The nature of the radicals produced has been
proved by adding SOD, that promoted a complete
inhibition of superoxide production during 1 mM
anthraquinone metabolism. With menadione, only a
partial inhibition was observed. This di¡erence may
be explained by SOD ability to dismute both super-
oxide and semiquinone radicals. Semiquinone radical
dismutation depends on the quinone reduction po-
tential E17 that should not be less than 3280 mV
[44,45]. We recently showed that the reduction po-
tentials of menadione and anthraquinone were
E17 =3162 and E
1
7 =3375 mV, respectively [32].
Thus, SOD catalyses both superoxide and menadione
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radical dismutation, explaining the apparent incom-
plete inhibition of superoxide formation.
The production of superoxide anions by cultured
endothelial cells was practically linear up to 30 min,
then a plateau appeared, suggesting a saturation or
an inhibition of the mechanism after this period. The
detection of superoxide anions in the extracellular
medium suggests that intracellular superoxide can
di¡use through the plasma membrane, probably via
an ionic channel as described in blood cells [46] or in
cat cerebral cells [14]. Numerous studies have also
demonstrated the release of superoxide radicals by
primary cultures of neurones in diverse experimental
conditions, for instance during hypoxia/reoxygena-
tion sequences [23], or during a treatment with ex-
citatory amino acids [47]. Nevertheless, both brain
microvessels and brain capillary endothelial cells in
primary cultures possess relatively large quantities of
e⁄cient antioxidants, including SOD activity, able to
neutralise superoxide anions and inhibit their poten-
tial harmful e¡ects [6,8]. These proteins allow endo-
thelial cells to inactivate in part the formed radicals.
Moreover, as endothelial cells contain nitric oxide
synthase, a part of superoxide may react with nitric
oxide to form peroxynitrite, which displays a greater
toxicity than superoxide [48]. Accordingly, both SOD
and N-g-nitro-L-arginine methyl ester (L-NAME), an
inhibitor of nitric oxide synthase in the brain [49],
inhibit cerebral endothelial cell injury promoted by
anoxia-reoxygenation [50]. Thus, the measurement of
superoxide released into the surrounding medium
concerns only a di¡usible part of superoxide radicals
formed during xenobiotic metabolism, suggesting
that the actual production should be higher than
that experimentally measured in the incubation me-
dium.
The present work also demonstrated that both as-
trocytes and neurones may produce superoxide when
they are exposed to permeant molecules that undergo
NADPH-dependent redox cycling. Even if the low
concentrations of diquat used in this work were in-
e⁄cient to promote signi¢cant superoxide release,
this explains some aspects of the neurotoxicity of
paraquat, a diquat-related molecule, which promotes
neuronal death through superoxide production when
administered by microdialysis into rat spinal cord
[51] or dopaminergic neurone depletion when in-
jected directly in animal brain [52]. The toxicity
risk is also reinforced by the high Vmax values for
xenobiotic metabolism in astrocytes, although these
cells possess high levels of glutathione and related
antioxidant metabolic activities able to neutralise
superoxide [53,54].
NADPH-cytochrome P450 reductase acts as an
electron donor during the metabolism of xenobiotics
by the cytochrome P450-dependent monooxygenase
system and can produce superoxide radicals during
their redox cycling. Astrocytes display a 2-fold higher
reductase activity than neurones or BEC, and this
higher activity is correlated with the higher superox-
ide production in cultured astrocytes and with the
higher Vmax value for menadione metabolism. In
the same way, an inhibition of NADPH-cytochrome
P450 reductase activity either by DPC or by the spe-
ci¢c polyclonal antibody raised against this enzyme,
promoted a comparable inhibition of superoxide pro-
duction. Moreover, it has been previously shown [40]
that the presence of cytochrome P450 inhibitors, n-
octylamine and SKF 525A, do not alter superoxide
production in rat brain microsomes in the same ex-
perimental conditions. Therefore, the present results
suggest that NADPH-cytochrome P450 reductase,
but not cytochrome P450, appears to be the main
enzyme involved in the NADPH-dependent xenobi-
otic metabolism which triggers superoxide produc-
tion.
In conclusion, the present results show that some
xenobiotics, when added to the culture medium of
cerebrovascular endothelial cells may promote an
NADPH-dependent superoxide overproduction cata-
lysed by NADPH-cytochrome P450 reductase. This
strongly suggests that in vivo, drugs or other xeno-
biotics present in cerebral circulation can promote an
oxidative damage at the BBB, resulting in an increase
in its passive permeability, thus allowing some access
of xenobiotics to the CNS. This should result in dis-
turbances in CNS homeostasis, as a subsequent
superoxide radical overproduction can also occur in
astrocytes and neurones.
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